Japan approves ITP drug Revolade

Japan's Ministry of Health, Labor and Welfare (MHLW) approved Revolade eltrombopag from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to treat chronic idiopathic thrombocytopenic purpura (ITP). Revolade ( P...